Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
-93.81%
Change (1 year)
Categories
Mallinckrodt Pharmaceuticals (MNK) - Total assets
Total assets on the balance sheet as of June 2023 : $5.10 B
According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's total assets are $5.10 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Mallinckrodt Pharmaceuticals - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $6.01 B | -32.55% |
| 2021-12-31 | $8.91 B | -8.23% |
| 2020-12-31 | $9.71 B | -6.03% |
| 2019-12-31 | $10.33 B | -4.95% |
| 2018-12-31 | $10.87 B | -28.82% |
| 2017-12-31 | $15.28 B | |
| 2016-09-30 | $15.49 B | -5.52% |
| 2015-09-30 | $16.40 B | 27.51% |
| 2014-09-30 | $12.86 B | 261.72% |
| 2013-09-30 | $3.55 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 3,181.01% | 🇺🇸 USA |
 General Electric GE | $163.94 B | 3,110.21% | 🇺🇸 USA |
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $43.47 B | 751.38% | 🇮🇱 Israel |